Found 115 with Last Name = 'bab' and Initial = 'i' TargetCannabinoid receptor 1(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 2.94nM ΔG°: -49.5kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 6nM ΔG°: -47.7kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 14nM ΔG°: -45.6kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 56.8nM ΔG°: -42.0kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 77.1nM ΔG°: -41.3kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 81.5nM ΔG°: -41.1kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 84.6nM ΔG°: -41.0kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 106nM ΔG°: -40.5kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 168nM ΔG°: -39.3kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 230nM ΔG°: -38.5kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 704nM ΔG°: -35.7kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 1.15E+3nM ΔG°: -34.5kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 1.27E+3nM ΔG°: -34.2kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 1.37E+3nM ΔG°: -34.0kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 1.50E+3nM ΔG°: -33.8kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 1.72E+3nM ΔG°: -33.5kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 2.51E+3nM ΔG°: -32.5kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 6.46E+3nM ΔG°: -30.1kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 7.91E+3nM ΔG°: -29.6kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: >1.00E+4nM ΔG°: >-29.0kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: >1.00E+4nM ΔG°: >-29.0kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataKi: 1.17E+4nM ΔG°: -28.6kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 7(Homo sapiens (Human))
Weizmann Institute Of Science
Curated by ChEMBL
Weizmann Institute Of Science
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Inhibition of N-terminal 6XHis-tagged recombinant MKK7 (117 to 423 residues) (unknown origin) expressed in Escherichia coli BL21-DE3 preincubated for...More data for this Ligand-Target Pair
3D Structure (crystal)TargetDual specificity mitogen-activated protein kinase kinase 7(Homo sapiens (Human))
Weizmann Institute Of Science
Curated by ChEMBL
Weizmann Institute Of Science
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of N-terminal 6XHis-tagged recombinant MKK7 (117 to 423 residues) (unknown origin) expressed in Escherichia coli BL21-DE3 preincubated for...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 7(Homo sapiens (Human))
Weizmann Institute Of Science
Curated by ChEMBL
Weizmann Institute Of Science
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of N-terminal 6XHis-tagged recombinant MKK7 (117 to 423 residues) (unknown origin) expressed in Escherichia coli BL21-DE3 preincubated for...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 7(Homo sapiens (Human))
Weizmann Institute Of Science
Curated by ChEMBL
Weizmann Institute Of Science
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of N-terminal 6XHis-tagged recombinant MKK7 (117 to 423 residues) (unknown origin) expressed in Escherichia coli BL21-DE3 preincubated for...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 7(Homo sapiens (Human))
Weizmann Institute Of Science
Curated by ChEMBL
Weizmann Institute Of Science
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of N-terminal 6XHis-tagged recombinant MKK7 (117 to 423 residues) (unknown origin) expressed in Escherichia coli BL21-DE3 preincubated for...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataIC50: 117nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataIC50: 162nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataIC50: 239nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataIC50: 313nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataIC50: 321nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataIC50: 330nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataIC50: 385nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataIC50: 425nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataIC50: 925nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataIC50: 1.15E+3nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataIC50: 1.53E+3nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataIC50: 2.09E+3nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataIC50: 2.29E+3nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataIC50: 3.37E+3nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataEC50: 136nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataEC50: 26.4nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataEC50: 126nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataEC50: 344nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataEC50: 185nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataEC50: 577nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Yissum Research Development Company of The Hebrew University of Jerusalem
US Patent
Affinity DataEC50: 18.3nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1/beta-2/gamma-2(Homo sapiens (Human))
University Of Graz
Curated by ChEMBL
University Of Graz
Curated by ChEMBL
Affinity DataEC50: 5.30E+3nMAssay Description:Allosteric modulation of GABAAalpha1beta2gamma2s receptor (unknown origin) expressed in Xenopus laevis oocytes assessed as potentiation of GABA-induc...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1/beta-2/gamma-2(Homo sapiens (Human))
University Of Graz
Curated by ChEMBL
University Of Graz
Curated by ChEMBL
Affinity DataEC50: 4.76E+4nMAssay Description:Allosteric modulation of GABAAalpha1beta2gamma2s receptor (unknown origin) expressed in Xenopus laevis oocytes assessed as potentiation of GABA-induc...More data for this Ligand-Target Pair
